Back
Avalo Therapeutics Stock Predictions
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
2
AVTX
Avalo Therapeutics
Last Price:
$4.75
Seasonality Move:
-21.62%
7 Day Trial
ALL ACCESS PASS
$
7
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Avalo Therapeutics Stock Forecast
-
Is Avalo Therapeutics Stock Undervalued?The current Avalo Therapeutics [AVTX] share price is $4.94. The Score for AVTX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
-
AVTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Avalo Therapeutics Stock Go Up Next Year?
Data Unavailable
Avalo Therapeutics Stock Rating
Data Unavailable
Avalo Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
avalotx.com
52-Week Data
52-Week High:
18.79
52-Week Low:
4.44
Prediction Charts
Market Cap:
52.7M
Price in USD:
4.94
Volume:
63.1K
Beta:
1.20
Technical Analysis
SMA50:
7.44
SMA100:
8.26
SMA200:
9.55
52-Wk Change:
-67.2%
Stock Predictions
-
Is Avalo Therapeutics stock public?Yes, Avalo Therapeutics is a publicly traded company.
-
What is the Avalo Therapeutics stock quote today?The Avalo Therapeutics stock price is 4.94 USD today.
-
How to buy Avalo Therapeutics stock online?You can buy Avalo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-24 | 7.60 | 7.63 | 7.63 | 6.98 |
| Mar-25 | 8.47 | 8.54 | 9.70 | 8.14 |
| Mar-26 | 8.90 | 8.36 | 8.99 | 8.04 |
| Mar-27 | 8.40 | 8.73 | 9.00 | 7.88 |
| Mar-28 | 8.57 | 8.46 | 8.90 | 8.16 |
| Mar-31 | 8.17 | 8.01 | 8.46 | 7.72 |
| Apr-1 | 8.37 | 6.85 | 8.37 | 6.81 |
| Apr-2 | 6.98 | 7.08 | 7.41 | 6.98 |
| Apr-3 | 6.90 | 6.59 | 7.00 | 6.40 |
| Apr-4 | 6.52 | 5.80 | 6.52 | 5.56 |
| Apr-7 | 5.71 | 5.76 | 5.93 | 5.00 |
| Apr-8 | 6.31 | 5.49 | 6.66 | 5.36 |
| Apr-9 | 5.43 | 5.10 | 5.44 | 5.02 |
| Apr-10 | 5.16 | 4.94 | 5.75 | 4.44 |
Avalo Therapeutics Earnings
Data Unavailable
Avalo Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $3.33 per share, a decrease next quarter of $0.46 per share, a decrease this year of $18.12 per share, and an increase next year of $1.00 per share.
* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.